AAAA Auralite Investments Inc

Auralite Investments Inc. (TSX Venture-AAAA) (the "Company" or "Auralite"), is pleased to provide an update on its strategic investee, Champignon Brands Inc. (“Champignon”).

Champignon has advised Auralite that it has successfully debuted its Vitality Superteas global e-commerce portal, following a comprehensive Canadian pilot campaign. Champignon’s flagship e-commerce store includes a selection of craft mushroom-infused teas and ancillary accessories, earmarked for worldwide distribution. At this time, Champignon is accepting pre-orders for its three premier mushroom-infused SKUs, Brain Enhance, Nourish Force and Mighty Re-charge, and has begun discussions with certain Canadian big box food retailers, as well as wholesalers regarding brick and mortar distribution of the Vitality Superteas. Champignon has also begun architecting a pop-up store for deployment within an existing Toronto-based coffee shop.

Robert Meister, Chief Executive Officer and a Director of Auralite stated: “We continue to be encouraged by the recent growth within the bourgeoning health and wellness vertical and are actively looking to deploy additional capital into promising, high growth companies. Auralite’s dedicated Health and Wellness committee is currently evaluating complimentary investments within the medicinal mushroom sector”.

ABOUT AURALITE

Auralite is an investment issuer with interests in Canadian-based Champignon Brands Inc., Singapore-based EVVO Labs Pte. Ltd. and South Korea-based Fourth-Link Inc.

ON BEHALF OF AURALITE INVESTMENTS INC. BOARD OF DIRECTORS

“Robert Meister”

For more information contact:(604) 351-6647

Or Email: rob@auraliteinvestments.comhttp://www.auraliteinvestments.com/

Reader Advisory

Statements and information contained in this news release relating to Champignon have been furnished by Champignon and the Company has relied upon Champignon to ensure that the news release contains full, true and plain disclosure.  Although the Company has no knowledge that would indicate that any statements contained herein concerning Champignon are untrue or incomplete, neither the Company nor any of its directors or officers assumes any responsibility for the accuracy or completeness of such statements and information or for any failure by Champignon to ensure disclosure of events or facts that may occur which may affect the significance or accuracy of any such information.

This news release contains forward-looking statements including statements regarding the Company’s plans to pursue further investments in the medicinal mushroom sector and management's beliefs as to potential opportunities in the health and wellness sector, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business and future prospects of the Company.

The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.